Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids
- PMID: 18443641
Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids
Abstract
Therapeutic opioid use and abuse coupled with the nonmedical use of other psychotherapeutic drugs has shown an explosive growth in recent years and has been a topic of great concern and controversy. Americans, constituting only 4.6% of the world's population, have been consuming 80% of the global opioid supply, and 99% of the global hydrocodone supply, as well as two-thirds of the world's illegal drugs. With the increasing therapeutic use of opioids, the supply and retail sales of opioids are mirrored by increasing abuse in patients receiving opioids, nonmedical use of other psychotherapeutic drugs (in this article the category of psychotherapeutics includes pain relievers, tranquilizers, stimulants, and sedatives, but does not include over-the-counter drugs), emergency department visits for prescription controlled drugs, exploding costs, increasing incidence of side effects, and unintentional deaths. However, all these ills of illicit drug use and opioid use, abuse, and non-medical use do not stop with adults. It has been shown that 80% of America's high school students, or 11 million teens, and 44% of middle school students, or 5 million teens, have personally witnessed, on the grounds of their schools, illegal drug use, illegal drug dealing, illegal drug possession, and other activities related to drug abuse. The results of the 2006 National Survey on Drug Use and Health showed that 7.0 million or 2.8% of all persons aged 12 or older had used prescription type psychotherapeutic drugs nonmedically in the past month, 16.387 million, or 6.6% of the population, had used in the past year, and 20.3%, or almost 49.8 million, had used prescription psychotherapeutic drugs nonmedically during their lifetime. Sadly, the initiates of psychotherapeutic drugs used for nonmedical purposes were highest for opioids. Therapeutic opioid use has increased substantially, specifically of Schedule II drugs. Apart from lack of effectiveness (except for short-term, acute pain) there are multiple adverse consequences including hormonal and immune system effects, abuse and addiction, tolerance, and hyperalgesia. Patients on long-term opioid use have been shown to increase the overall cost of healthcare, disability, rates of surgery, and late opioid use.
Similar articles
-
Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective.Pain Physician. 2010 Sep-Oct;13(5):401-35. Pain Physician. 2010. PMID: 20859312
-
Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.Pain Physician. 2009 Jan-Feb;12(1):259-67. Pain Physician. 2009. PMID: 19165308 Clinical Trial.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
National drug control policy and prescription drug abuse: facts and fallacies.Pain Physician. 2007 May;10(3):399-424. Pain Physician. 2007. PMID: 17525776 Review.
-
The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).Pain Med. 2007 Mar;8(2):157-70. doi: 10.1111/j.1526-4637.2006.00259.x. Pain Med. 2007. PMID: 17305687
Cited by
-
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi-ascending dose study with a bioequivalence arm in healthy volunteers.Clin Transl Sci. 2024 Mar;17(3):e13765. doi: 10.1111/cts.13765. Clin Transl Sci. 2024. PMID: 38511523 Free PMC article. Clinical Trial.
-
Body Mass Index Trends among a Cohort of Subjects Enrolled in Medication-Assisted Treatment Programmes for Opioid Use Disorder: Racial/Ethnic, Gender, and Age Differences.J Food Nutr Metab. 2023;5(1):10.31487/j.JFNM.2022.01.01. doi: 10.31487/j.JFNM.2022.01.01. Epub 2023 May 24. J Food Nutr Metab. 2023. PMID: 38370009 Free PMC article.
-
Opioid Prescribing Patterns After Colorectal Resections in the United States of America.Cureus. 2023 Nov 16;15(11):e48890. doi: 10.7759/cureus.48890. eCollection 2023 Nov. Cureus. 2023. PMID: 38106740 Free PMC article.
-
Providers' Perceptions of the Effectiveness of Electronic Health Records in Identifying Opioid Misuse.J Healthc Manag. 2023 Nov-Dec 01;68(6):390-403. doi: 10.1097/JHM-D-22-00253. J Healthc Manag. 2023. PMID: 37944171 Free PMC article.
-
Efficacy of regional anesthesia in hip preservation surgeries: a systematic review.J Hip Preserv Surg. 2023 Apr 15;10(2):87-103. doi: 10.1093/jhps/hnad008. eCollection 2023 Jul. J Hip Preserv Surg. 2023. PMID: 37900889 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous